---  
layout: startup_page  
title: "NeoPhore Limited"  
id: "neophore.com"  
permalink: "/neophorelimitedneophore.com05222024/"  
website: "https://www.neophore.com/"  
funding_round: "Series B+"  
funding_amount: ""  
investors: "Bristol Myers Squibb"  
about: "NeoPhore Limited is a small molecule neoantigen immuno-oncology company focused on developing a pipeline of small molecule drugs targeting novel proteins across the MMR pathway. Their first-in-class MMR inhibitors aim to improve clinical outcomes for cancer patients by inducing neoantigen expression and increasing immunogenicity in solid tumors. This approach makes the tumors more sensitive to immunotherapy."  
markets: "Immuno-oncology, Oncology, Biotechnology, Drug Discovery, Small Molecule Therapeutics, Cancer, Genetics, and Translational Medicine"  
hq: "Cambridge, Cambridgeshire, United Kingdom"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/neophore-ltd"  
twitter: "https://twitter.com/neophoreltd"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/neophore"  
pitchbook: "https://pitchbook.com/profiles/company/222255-64"  

date_display: "22-May-2024"  
date: "2024-05-22"

# SEO Optimization  
meta_title: "NeoPhore Limited - Series B+"  
meta_description: "NeoPhore Limited, NeoPhore Limited is a small molecule neoantigen immuno-oncology company focused on developing a pipeline of small molecule drugs targeting novel prote..."  
meta_keywords: "NeoPhore Limited, Immuno-oncology, Oncology, Biotechnology, Drug Discovery, Small Molecule Therapeutics, Cancer, Genetics, and Translational Medicine, Series B+ funding"  
canonical_url: "https://startup.projectstartups.com/neophorelimitedneophore.com05222024/"  
---